PMID- 36276133
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221025
IS  - 2234-943X (Print)
IS  - 2234-943X (Electronic)
IS  - 2234-943X (Linking)
VI  - 12
DP  - 2022
TI  - Effectiveness and safety of self-pulling and latter transected Roux-en-Y 
      reconstruction in totally laparoscopic distal gastrectomy.
PG  - 916692
LID - 10.3389/fonc.2022.916692 [doi]
LID - 916692
AB  - BACKGROUND: Self-pulling and latter transection (SPLT) reconstruction has been 
      applied in total laparoscopic total gastrectomy and BI reconstruction (known as 
      Delta SPLT) in total laparoscopic distal gastrectomy (TLDG) in some previous 
      studies. This approach can reduce the technical difficulty of the surgery as well 
      as the quantity of cartridges required, with manageable safety. Here, we used 
      SPLT to complete Roux-en-Y reconstruction in TLDG and evaluated the safety and 
      effectiveness of this novel method by comparing it with conventional Roux-en-Y 
      reconstruction in laparoscopy-assisted distal gastrectomy (LADG). METHODS: 
      Patients with gastric cancer who underwent SPLT-TLDG or LADG between June 2019 
      and September 2021 were retrospectively analyzed. Baseline information and 
      postoperative short-term surgical outcomes of the two groups were compared. 
      RESULTS: A total of 114 patients with gastric cancer were included in the study. 
      Patients underwent SPLT-TLDG (n = 73, 64.0%) or LADG (n = 41, 36.0%). No patient 
      underwent open surgery. There were no differences in patient demographics or 
      tumor characteristics between the two groups. The mean intraoperative blood loss 
      was 47.1 +/- 34.3 ml in the SPLT-TLDG group, which was significantly less than that 
      in the LADG group (P = 0.022). There were no significant differences in operation 
      time, harvested lymph nodes, time to first flatus, time to liquid intake, or 
      postoperative hospital stay between the two groups. Nine and five patients had 
      short-term postoperative complications in the SPLT-TLDG and LADG groups, 
      respectively. CONCLUSION: We introduced a self-pulling and latter transected 
      Roux-en-Y reconstruction (SPLT-RY) for use in TLDG. We showed that SPLT-RY 
      reconstruction in TLDG is a safe and feasible surgical method in terms of 
      short-term surgical outcomes and has the advantages of simplifying the 
      reconstruction.
CI  - Copyright (c) 2022 Chen, Yang, Woraikat, Tang and Qian.
FAU - Chen, Defei
AU  - Chen D
AD  - Department of Gastrointestinal Surgery, The First Affiliated Hospital of 
      Chongqing Medical University, Chongqing, China.
FAU - Yang, Fuyu
AU  - Yang F
AD  - Department of Gastrointestinal Surgery, The First Affiliated Hospital of 
      Chongqing Medical University, Chongqing, China.
FAU - Woraikat, Saed
AU  - Woraikat S
AD  - Department of Gastrointestinal Surgery, The First Affiliated Hospital of 
      Chongqing Medical University, Chongqing, China.
FAU - Tang, Chenglin
AU  - Tang C
AD  - Department of Gastrointestinal Surgery, The First Affiliated Hospital of 
      Chongqing Medical University, Chongqing, China.
FAU - Qian, Kun
AU  - Qian K
AD  - Department of Gastrointestinal Surgery, The First Affiliated Hospital of 
      Chongqing Medical University, Chongqing, China.
LA  - eng
PT  - Journal Article
DEP - 20221007
PL  - Switzerland
TA  - Front Oncol
JT  - Frontiers in oncology
JID - 101568867
PMC - PMC9585270
OTO - NOTNLM
OT  - Roux-en-Y reconstruction
OT  - gastric cancer
OT  - laparoscopy-assisted distal gastrectomy
OT  - self-pulling and latter transection
OT  - totally laparoscopic distal gastrectomy
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as potential a 
      conflict of interest.
EDAT- 2022/10/25 06:00
MHDA- 2022/10/25 06:01
PMCR- 2022/01/01
CRDT- 2022/10/24 04:11
PHST- 2022/04/09 00:00 [received]
PHST- 2022/09/16 00:00 [accepted]
PHST- 2022/10/24 04:11 [entrez]
PHST- 2022/10/25 06:00 [pubmed]
PHST- 2022/10/25 06:01 [medline]
PHST- 2022/01/01 00:00 [pmc-release]
AID - 10.3389/fonc.2022.916692 [doi]
PST - epublish
SO  - Front Oncol. 2022 Oct 7;12:916692. doi: 10.3389/fonc.2022.916692. eCollection 
      2022.